Microvasculopathy in the ocular fundus after bone marrow transplantation

Annals of Internal Medicine

Volumn 115, Issue 12, 1991, Pages 925-930

  Bernauer, Wolfgang ^a   Gratwohl, Alois ^a,b   Keller, Alexandre ^a,c   Daicker, Basil ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Augenarzt FMH ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; GRAFT VERSUS HOST REACTION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; OPHTHALMOSCOPY; ORAL DRUG ADMINISTRATION; PAPILLEDEMA; PRIORITY JOURNAL; RETINA ISCHEMIA; RISK ASSESSMENT; SCHOOL CHILD; VISUAL ACUITY; WHOLE BODY RADIATION;

EID: 0026320918     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-115-12-925     Document Type: Article

References (43)

1. Binaghi M, Sterkers M, Vernant JP, Coscas G. Micro-angiopathie thrombotique et ses manifestations oculaires: complication inhabituelle d'une greffe de moelle osseuse. [Thrombotic microangiopathy and its ocular manifestations: an unusual complication of bone marrow graft.] J Fr Ophthalmol. 1983;6:881-8.
2. Noll RB, Kulkarni R. Complex visual hallucinations and cyclosporine. Arch Neurol. 1984;41:329-30.
3. Gloor B, Gratwohl A, Hahn H, Kretzschmar S, Robert Y, Speck B, et al. Multiple cotton wool spots following bone marrow transplantation for treatment of acute lymphatic leukaemia. Br J Ophthalmol. 1985;69:320-5.
4. Pillunat LE, Schmeiser T, Greber H. Toxische Retinopathie unter Cyclosporin A Therapie [Toxic retinopathy in cyclosporin A therapy.] Klin Monatsbl Augenheilk. 1987;190:131-4.
5. Vogler WR, Winton EF, Heffner LT, Gordon DS, Sternberg P, Crocker I, et al. Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation. Bone Marrow Transplant. 1990;6:405-9.
6. Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB. Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med. 1984;101:667-82.
7. Gratwohl A, Speck B. Bone marrow transplantation with cyclosporin. Prog Allergy. 1986;38:404-31.
8. Nussenblatt RB, Palestine AG. Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol. 1986;31:159-69.
9. Frey FJ. Cyclosporin bei Autoimmunkrankheiten [Cyclosporin in autoimmune diseases]. Schweiz Med Wochenschr. 1990;120:772-86.
10. Walfe JA, McCann RL, Sanfilippo F. Cyclosporine-associated microangiopathy in renal transplantation: a severe but potentially reversible form of early graft injury. Transplantation. 1986;41:541-4.
11. Mihatsch MJ, Bach JF, Coovadia HM, Forre O, Moutsopoulos HM, Drosos AA, et al. Cyclosporin-associated nephropathy in patients with autoimmune diseases. Klin Wochenschr. 1988;66:43-7.
12. Dieterle A, Gratwohl A, Nizze H, Huser B, Mihatsch MJ, Thiel G, et al. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients. Transplantation. 1990;49:1093-100.
13. Joes DV, Barrett AJ, Kendra JR, Lucas CF, Desai S. Hypertension and convulsions in children receiving cyclosporin A [Letter]. Lancet. 1982;1:906.
14. Hamilton DV, Carmichael DJ, Evans DB, Calne RY. Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine. Transplant Proc. 1982;14:597-600.
15. Palestine AG, Nussenblatt RB, Chan CC. Side effects of systemic Cyclosporine in patients not undergoing transplantation. Am J Med. 1984;77:652-6.
16. Gratwohl A, Gloor B, Hahn H, Speck B. Retinal cottoo-wool patches in bone-marrow-transplant recipients. N Engl J Med. [Letter]. 1983;308:1101.
17. Speck B, Gratwohl A, Tichelli A, Würsch A. Critical hypothesis on cyclosporine in bone marrow transplantation. Transplant Proc. 1988;20:505-15.
18. Speck B, Nissen C, Ticbelli A, Roth J, Dazzi H, Stebler R, et al. Bone marrow transplantation in Basel: single center experience from 1973 to 1989. In: Terasaki PI, ed. Clinical Transplant 1989. Los Angeles: UCLA Tissue Typing Laboratory: 1989:115-22.
19. Gratwohl A, Moutsopoulos HM, Chused TM, Akizuki M, Wolf RO, Sweet JB, et al. Sjogren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med. 1977;87:703-6.
20. Hirst WL, Jabs DA, Tutschka PJ, Green WR, Santos GW. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol. 1983;101:580-4.
21. Jabs DA, Hirst LW, Green WR, Tutschka PJ, Santos GW, Beschorner WE. The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol. 1983;101:585-90.
22. Livesey SJ, Holmes JA, Whittaker JA. Ocular complications of bone marrow transplantation. Eye. 1989;3:271-6.
23. Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GW. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983;90:4-13.
24. Jack MK, Jack GM, Sale GE, Shulman HM, Sullivan KM. Ocular manifestations of graft-v-host disease. Arch Ophthalmol. 1983;101: 1080-4.
25. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy. Ophthalmology. 1986;93:74-87.
26. Hayreh SS, Servais GE, Virdi PS. Retinal lipid deposits in malignant arterial hypertension. Ophthalmologica. 1989;198:216-29.
27. Duke-Elder S, MacFaul PA. System of Ophthalmology, v. 10. London: Henry Kimpton Publishers, Ltd.; 1967:23-24.
28. Pomerantz RJ, Kuritzkes DR, de la Monte SM, Rota TR, Baker AS, Albert D, et al. Infection of the retina by human immunodeficiency virus type I. N Engl J Med. 1987;317:1643-1647.
29. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology. 1985;92:472-84.
30. Bloom JN, Palestine AG. The diagnosis of cytomegalovirus retinitis. Ann Intern Med. 1988;109:963-9.
31. Bernauer W, Daicker B. CMV-Retinitis bei AIDS - eine präfinale komplikation? (Cytomegalovirus retinitis in AIDS - a prefinal complication?) Klin Monatsbl Augenheilkd. 1991;198:447-50.
32. Daicker B. Cytomegalovirus panuveitis with infection of corneotrabecular endothelium in AIDS. Ophthalmologica. 1988;197:169-75.
33. Hayreh SS, Servais GE, Virdi PS. Retinal arteriolar changes in malignant arterial hypertension. Ophthalmologica. 1989;198:178-96.
34. Hayreh SS, Servais GE, Virdi PS. Cotton-wool spots (inner retinal ischemic spots) in malignant arterial hypertension. Ophthalmologica. 1989;198:197-215.
35. Hayreh SS, Servais GE, Virdi PS. Macular lesions in malignant arterial hypertension. Ophthalmologica. 1989;198:230-46.
36. Leishman R. The eye in general vascular disease. Br J Ophthalmol. 1957;41:641-701.
37. Oechslin M, Thiel G, Landmann J, Gloor B. Cotton-wool exudates not observed in recipients of renal transplants treated with cyclosporine. Transplantation. 1986;41:60-2.
38. Kinyoun JL, Chittum ME, Wells CG. Photocoagulation treatment of radiation retinopathy. Am J Ophthalmol. 1988;105:470-8.
39. Brown GC, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Schatz NJ. Radiation retinopathy. Ophthalmology. 1982;89:1494-501.
40. Kinyoun JL, Kalina RE, Brower SA, Mills RP, Johnson RH. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Arch Ophthalmol. 1984;102:1473-6.
41. Duke-Elder S, MacFaul PA. System of Ophthalmology. London: Henry Kimpton Publishers Ltd; 1972;981.
42. Merriam GR, Szechter A, Focht EF. The effects of ionizing radiations on the eye. Radiat Ther Oncol. 1972;6:346.
43. Coccia PF, Strandjord SE, Warkentin PI, Ceung NV, Gordon EM, Novak LJ, et al. High-dose cytosine arabinoside and fractionated total body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood. 1988;71:888-93.